Zoetis, formerly the animal health division of Pfizer, officially separated from Pfizer in June 2013 through a share exchange, becoming a fully independent company and joining the S&P 500® Pharmaceuticals sub-sector index. Revenue for the 12 months ended September 30, 2012, reached $4.3 billion. The company specializes in the research and development and production of vaccines, diagnostics, and veterinary medicines, with operations in over 100 countries, 28 facilities, and 9,500 employees. Its products cover a wide range of categories, including pets, livestock, and poultry. The company continues to invest in research and development, with a research and development center in Michigan, USA. Earnings per share are expected to grow by 11% in the fourth quarter of 2019, and Zoetis ranked 440th on the Fortune 500 list that same year.

Zoetis is the world's largest manufacturer of pharmaceuticals and vaccines for pets and livestock. Zoetis is a publicly traded subsidiary of Pfizer, the world's largest pharmaceutical manufacturer, in which Pfizer holds an 83% stake. The company operates in 70 countries worldwide, recently expanding into Southeast Asia and China.
In the 1950s, Pfizer began researching various drugs, including oxytetracycline. John McKeen, a chemical engineer who worked on Pfizer products, discovered its effectiveness in livestock. In 1952, Pfizer's agricultural division opened Vigo, a 732-acre research and development facility in Terre Haute, Indiana. In 1988, the division was renamed Pfizer Animal Health.
Company Name: Zoetis.
Official Domain: zoetis.com.
Domain Creation: December 22, 2011.
Country: United States.
Headquarters: Parsippany, USA.
Founded: 2013.